Skip to Main Content

Author Details

William A Fischer
University of North Carolina School of Medicine
1999
69
25
PMIDPaper TitleJournal TitlePublished Year
36065768Post-Ebola Symptoms 7 Years After Infection: The Natural History of Long Ebola.Clin Infect Dis2023
37650230Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19.J Infect Dis2023
35712994Creation and impact of containment units with high-risk zones during the coronavirus disease 2019 (COVID-19) pandemic.Infect Control Hosp Epidemiol2023
37099295Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials.JAMA Netw Open2023
37068272Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.Ann Intern Med2023
36996258A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.PLoS One2023
36658128Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.Nat Commun2023
35022711Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates.Clin Infect Dis2022
35793677Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection.Cell Rep Med2022
35850699The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone.BMC Infect Dis2022
36480499Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center.PLoS One2022
35995785Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.Nat Commun2022
35315712Longitudinal SARS-CoV-2 Testing among the Unvaccinated Is Punctuated by Intermittent Positivity and Variable Rates of Increasing Cycle Threshold Values.Microbiol Spectr2022
35184085Major Bleeding and Thrombosis Events in COVID-19 Versus Influenza Patients Requiring Extracorporeal Membrane Oxygenation.ASAIO J2022
34941423A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus.Sci Transl Med2022
35298899Inequities in access to diagnostics threatens global public health security.Lancet Infect Dis2022
34048568Outpatient Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Infection to Prevent Coronavirus Disease 2019 Progression.Clin Infect Dis2021
33627703Highly dampened blood transcriptome response in HIV patients after influenza infection.Sci Rep2021
33822010Post-Ebola Syndrome Presents With Multiple Overlapping Symptom Clusters: Evidence From an Ongoing Cohort Study in Eastern Sierra Leone.Clin Infect Dis2021
34981077Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19: A Phase 2 Randomized Clinical Trial.medRxiv2021
35018382Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection.medRxiv2021
34455583First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19.Clin Pharmacol Ther2021
34626958Rapid analysis of local data to inform off-label tocilizumab use early in the COVID-19 pandemic.Healthc (Amst)2021
34159342Molnupiravir, an Oral Antiviral Treatment for COVID-19.medRxiv2021
34100024Infectious SARS-CoV-2 Virus in Symptomatic COVID-19 Outpatients: Host, Disease, and Viral Correlates.medRxiv2021
34059750Author Correction: Highly dampened blood transcriptome response in HIV patients after respiratory infection.Sci Rep2021
31629226Runaway Kaposi Sarcoma-associated herpesvirus replication correlates with systemic IL-10 levels.Virology2020
32080199Ebola virus disease.Nat Rev Dis Primers2020
31693114Long-term Complications of Ebola Virus Disease: Prevalence and Predictors of Major Symptoms and the Role of Inflammation.Clin Infect Dis2020
32925964The impact of semen testing for Ebola virus RNA on sexual behavior of male Ebola survivors in Liberia.PLoS Negl Trop Dis2020
32153113Burden of respiratory viral infection in persons with human immunodeficiency virus.Influenza Other Respir Viruses2020
30970184Shifting the Paradigm - Applying Universal Standards of Care to Ebola Virus Disease.N Engl J Med2019
30926957New filovirus disease classification and nomenclature.Nat Rev Microbiol2019
29054555Evidence-based guidelines for supportive care of patients with Ebola virus disease.Lancet2018
30073287Gaps in the Clinical Management of Influenza: A Century Since the 1918 Pandemic.JAMA2018
29878083Age-Associated Changes in the Respiratory Epithelial Response to Influenza Infection.J Gerontol A Biol Sci Med Sci2018
30485311Stigma and Ebola survivorship in Liberia: Results from a longitudinal cohort study.PLoS One2018
29688496ZMapp Reinforces the Airway Mucosal Barrier Against Ebola Virus.J Infect Dis2018
29659889Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease.J Infect Dis2018
29153266Ebola virus disease: an update on post-exposure prophylaxis.Lancet Infect Dis2018
27393614Apheresis for collection of Ebola convalescent plasma in Liberia.J Clin Apher2017
29670927Ebola Virus Ribonucleic Acid Detection in Semen More Than Two Years After Resolution of Acute Ebola Virus Infection.Open Forum Infect Dis2017
29154748CDC Safety Training Course for Ebola Virus Disease Healthcare Workers.Emerg Infect Dis2017
28745014The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection.Influenza Other Respir Viruses2017
28863471Moving Lassa Fever Research and Care Into the 21st Century.J Infect Dis2017
27932614Validation of the Cepheid GeneXpert for Detecting Ebola Virus in Semen.J Infect Dis2017
27955778Screening of genital fluid for Ebola virus.Lancet Glob Health2017
26936667Confronting Ebola as a Sexually Transmitted Infection.Clin Infect Dis2016
27332916Convalescent Plasma for Ebola Virus Disease.N Engl J Med2016
27144786Responding to the Global Threat of High-Consequence Pathogens: Protecting Health Care Workers and Caring for Patients.Ann Am Thorac Soc2016
  • 1 - 50 of 69

Recommended Authors

Lakshmi Chauhan
University of Colorado School of Medicine
Career Start Year 2018
Number of shared co-authors 0
James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 8
Onyema Ogbuagu
Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 3
Leora R Feldstein
US Centers for Disease Control and Prevention
Career Start Year 2014
Number of shared co-authors 2
Melissa A Rolfes
Centers for Disease Control and Prevention
Career Start Year 2012
Number of shared co-authors 4
Mark W Tenforde
Centers for Disease Control and Prevention
Career Start Year 2011
Number of shared co-authors 1
Meagan E Deming
University of Maryland School of Medicine
Career Start Year 2011
Number of shared co-authors 3
Amalia Magaret
University of Washington
Career Start Year 2007
Number of shared co-authors 3
Emily T Martin
University of Michigan School of Public Health ann arbor
Career Start Year 2006
Number of shared co-authors 2
Helen K B Talbot
Vanderbilt University Medical Center
Career Start Year 2005
Number of shared co-authors 1
Emmie de Wit
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 9
Pavitra Roychoudhury
Fred Hutchinson Cancer Center
Career Start Year 2004
Number of shared co-authors 3
Diya Surie
Centers for Disease Control and Prevention
Career Start Year 2004
Number of shared co-authors 1
Natalie J Thornburg
Centers for Disease Control and Prevention (CDC)
Career Start Year 2003
Number of shared co-authors 7
Natasha B Halasa
Vanderbilt University Medical Center
Career Start Year 2002
Number of shared co-authors 3
Richard A Martinello
Yale University
Career Start Year 2002
Number of shared co-authors 1
Kayvon Modjarrad
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 8
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 7
Charles S Dela Cruz
Department of Microbial Pathogenesis Yale University New Haven
Career Start Year 1998
Number of shared co-authors 2
James D Chappell
Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 3
Meredith L McMorrow
Centers for Disease Control and Prevention
Career Start Year 1995
Number of shared co-authors 3
Priya Sampathkumar
Mayo Clinic
Career Start Year 1994
Number of shared co-authors 0
Christine C Ginocchio
United States Zucker School of Medicine at Hofstra/Northwell
Career Start Year 1992
Number of shared co-authors 2
Charles Y Chiu
University of California-San Francisco
Career Start Year 1991
Number of shared co-authors 9
Andrew T Pavia
University of Utah
Career Start Year 1987
Number of shared co-authors 6
Edward A Belongia
Marshfield Clinic Research Institute
Career Start Year 1987
Number of shared co-authors 1
Bart L Haagmans
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 7
Donald S Burke
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Career Start Year 1976
Number of shared co-authors 2
Arthur Reingold
University of California berkeley
Career Start Year 1971
Number of shared co-authors 0
Arnold S Monto
University of Michigan School of Public Health ann arbor
Career Start Year 1959
Number of shared co-authors 3

Collaborators

David A Wohl
The University of North Carolina School of Medicine
Co-authored papers 35
Joseph J Eron
Co-authored papers 14
Shevin T Jacob
Infectious Disease Institute, Makerere University
Co-authored papers 10
Robert A Fowler
Institute of Health Policy
Co-authored papers 9
John S Schieffelin
Tulane University
Co-authored papers 9
Daniel G Bausch
London School of Hygiene & Tropical Medicine
Co-authored papers 9
Judith S Currier
David Geffen School of Medicine, University of California los angeles
Co-authored papers 8
Eric S Daar
Co-authored papers 8
Tom E Fletcher
Royal Liverpool Hospital
Co-authored papers 8
Fran??ois Lamontagne
Universite de Sherbrooke
Co-authored papers 7
David M Brett-Major
College of Public Health, University of Nebraska Medical Center
Co-authored papers 6
Timothy M Uyeki
US Centers for Disease Control and Prevention
Co-authored papers 6
Ian Crozier
Christchurch Hospital
Co-authored papers 6
Ralph S Baric
University of North Carolina
Co-authored papers 5
Michael Jacobs
Royal Free NHS Foundation Trust
Co-authored papers 5
Srinivas Murthy
University of British Columbia
Co-authored papers 4
Frederique Jacquerioz
Geneva Center for Emerging Viral Diseases, Geneva University Hospitals
Co-authored papers 4
Tim O'Dempsey
University of Liverpool
Co-authored papers 4
Takuya Adachi
Adachi Mental Clinic
Co-authored papers 4
Pauline Vetter
University Hospital of Geneva
Co-authored papers 3
Ibrahima Bah
Donka National Hospital
Co-authored papers 3
Catherine F Houlihan
University College London Hospitals National Health Service Foundation Trust
Co-authored papers 3
Alexander L Greninger
University of Washington Medical Center
Co-authored papers 3
Neill K J Adhikari
University of Toronto
Co-authored papers 3
Davey M Smith
University of California San Diego
Co-authored papers 3
Moses J Soka
ELWA Hospital
Co-authored papers 3
Henry Kyobe Bosa
Ministry of Health
Co-authored papers 2
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers 2
Timothy H Burgess
Infectious Disease Clinical Research Program, Uniformed Services University
Co-authored papers 2
Aneesh K Mehta
Emory University School of Medicine
Co-authored papers 2
Release 1.2